NO20015378D0 - Cyclocarbamatderivater som progesteron reseptor modulatorer - Google Patents

Cyclocarbamatderivater som progesteron reseptor modulatorer

Info

Publication number
NO20015378D0
NO20015378D0 NO20015378A NO20015378A NO20015378D0 NO 20015378 D0 NO20015378 D0 NO 20015378D0 NO 20015378 A NO20015378 A NO 20015378A NO 20015378 A NO20015378 A NO 20015378A NO 20015378 D0 NO20015378 D0 NO 20015378D0
Authority
NO
Norway
Prior art keywords
receptor modulators
progesterone receptor
cyclocarbamate
derivatives
cyclocarbamate derivatives
Prior art date
Application number
NO20015378A
Other languages
English (en)
Other versions
NO321361B1 (no
NO20015378L (no
Inventor
Puwen Zhang
Eugene A Terefenko
III Horace FLETCHER
Andrew Fensome
Jay E Wrobel
Lin Zhi
Todd K Jones
Christopher M Tegley
James P Edwards
Original Assignee
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Ligand Pharm Inc filed Critical Ligand Pharm Inc
Publication of NO20015378D0 publication Critical patent/NO20015378D0/no
Publication of NO20015378L publication Critical patent/NO20015378L/no
Publication of NO321361B1 publication Critical patent/NO321361B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015378A 1999-05-04 2001-11-02 Cyklokarbamatderivater, deres bruk som medikament, et farmasoytisk preparat, samt anvendelse av derivatene for fremstilling av medikamenter. NO321361B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (3)

Publication Number Publication Date
NO20015378D0 true NO20015378D0 (no) 2001-11-02
NO20015378L NO20015378L (no) 2002-01-03
NO321361B1 NO321361B1 (no) 2006-05-02

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015378A NO321361B1 (no) 1999-05-04 2001-11-02 Cyklokarbamatderivater, deres bruk som medikament, et farmasoytisk preparat, samt anvendelse av derivatene for fremstilling av medikamenter.

Country Status (19)

Country Link
EP (1) EP1173426A1 (no)
JP (1) JP2002543193A (no)
KR (1) KR20010114250A (no)
CN (1) CN1145618C (no)
AU (1) AU766428B2 (no)
BG (1) BG106079A (no)
BR (1) BR0010213A (no)
CA (1) CA2371726A1 (no)
CZ (1) CZ20013951A3 (no)
EA (1) EA004512B1 (no)
HU (1) HUP0201609A3 (no)
IL (1) IL146280A0 (no)
MX (1) MXPA01011286A (no)
NO (1) NO321361B1 (no)
NZ (1) NZ515355A (no)
PL (1) PL351127A1 (no)
SG (1) SG114650A1 (no)
SK (1) SK15912001A3 (no)
TR (1) TR200103286T2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012402A (es) * 2004-04-27 2007-01-17 Wyeth Corp Carbamato y tiocarbamato biarilos ciclicos que contienen cianopirrol y metodos para preparar los mismos.
WO2006077821A1 (ja) * 2005-01-19 2006-07-27 Dainippon Sumitomo Pharma Co., Ltd. アルドステロン受容体調節剤としての芳香族スルホン化合物
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
CZ176197A3 (cs) * 1994-12-22 1998-09-16 Ligand Pharmaceuticals Incorporated Modulátory steroidových receptorů a způsoby jejich přípravy a použití
WO1998014436A1 (en) * 1996-10-02 1998-04-09 Dupont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
JP2002543193A (ja) 2002-12-17
PL351127A1 (en) 2003-03-24
HUP0201609A2 (en) 2002-08-28
EA200101176A1 (ru) 2002-04-25
BR0010213A (pt) 2002-02-19
NO321361B1 (no) 2006-05-02
NZ515355A (en) 2004-02-27
BG106079A (en) 2002-05-31
HUP0201609A3 (en) 2002-12-28
MXPA01011286A (es) 2003-07-14
IL146280A0 (en) 2002-07-25
SG114650A1 (en) 2005-09-28
SK15912001A3 (sk) 2002-06-04
AU766428B2 (en) 2003-10-16
KR20010114250A (ko) 2001-12-31
NO20015378L (no) 2002-01-03
CN1145618C (zh) 2004-04-14
AU4688600A (en) 2000-11-17
CA2371726A1 (en) 2000-11-09
EP1173426A1 (en) 2002-01-23
CN1349517A (zh) 2002-05-15
EA004512B1 (ru) 2004-04-29
CZ20013951A3 (cs) 2002-05-15
TR200103286T2 (tr) 2002-07-22

Similar Documents

Publication Publication Date Title
NO20015272L (no) Glukokortikoid reseptor modulatorer
NO20015314D0 (no) Steroidderivater
NO20051042L (no) Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer
DE60327767D1 (de) Tricyclische steroidhormonkernrezeptor-modulatoren
DK1284974T3 (da) Triazolyltropanderivater som CCR5-modulatorer
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
AU2003230581A1 (en) Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
NO20013997D0 (no) Reseptoranalyse
DK1027342T3 (da) Cyclopentenderivater som motilinreceptorantagonister
NO20013860L (no) 16-hydroksyöstratriener som selektive östrogener
HK1070362A1 (en) Non-steroidal progesterone receptor modulators
DK1467998T3 (da) Tetracykliske hetaroforbindelser som östrogenreceptormodulatorer
NO20015378D0 (no) Cyclocarbamatderivater som progesteron reseptor modulatorer
NO20021295D0 (no) Nikotinsyreacetylcholin-reseptor
NO20032415L (no) Forbindelser som er aktive på glukokortikoidreseptor II
HK1043989A1 (zh) 作為黃體酮受體調節劑的環胺基甲酸鹽衍生物
HK1043789A1 (zh) 作為黃體酮受體調節劑的環硫代胺基甲酸鹽衍生物
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
DK1159267T3 (da) N-substituerede indoliner som östrogene midler
FR2789393B1 (fr) Lactol steroidique

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application